These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 22794509)

  • 21. Sublineages of Mycobacterium tuberculosis Beijing genotype strains and unfavorable outcomes of anti-tuberculosis treatment.
    Hang NT; Maeda S; Keicho N; Thuong PH; Endo H
    Tuberculosis (Edinb); 2015 May; 95(3):336-42. PubMed ID: 25732626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Smear-negative' pulmonary tuberculosis in a DOTS programme: poor outcomes in an area of high HIV seroprevalence.
    Hargreaves NJ; Kadzakumanja O; Whitty CJ; Salaniponi FM; Harries AD; Squire SB
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):847-54. PubMed ID: 11573897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluoroquinolone resistance in Mycobacterium tuberculosis: the effect of duration and timing of fluoroquinolone exposure.
    Devasia RA; Blackman A; Gebretsadik T; Griffin M; Shintani A; May C; Smith T; Hooper N; Maruri F; Warkentin J; Mitchel E; Sterling TR
    Am J Respir Crit Care Med; 2009 Aug; 180(4):365-70. PubMed ID: 19483111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment Outcomes with Fluoroquinolone-Containing Regimens for Isoniazid-Resistant Pulmonary Tuberculosis.
    Lee H; Jeong BH; Park HY; Jeon K; Huh HJ; Lee NY; Koh WJ
    Antimicrob Agents Chemother; 2016 Jan; 60(1):471-7. PubMed ID: 26525801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA; Burhan E; Nawas A; Soepandi PZ; Sutoyo DK; Agustin H; Isbaniah F; Dowdy DW
    Int J Tuberc Lung Dis; 2014 May; 18(5):564-70. PubMed ID: 24903794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of gene xpert for routine diagnosis of HIV-associated tuberculosis in Nigeria: A prospective cohort study.
    Akanbi MO; Achenbach C; Taiwo B; Idoko J; Ani A; Isa Y; Agbaji O; Ukoli C; Akande P; Maiga M; Murphy RL
    BMC Pulm Med; 2017 May; 17(1):87. PubMed ID: 28558662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delays in care seeking, diagnosis and treatment among pulmonary tuberculosis patients in Shenzhen, China.
    Xu X; Liu JH; Cao SY; Zhao Y; Dong XX; Liang Y; Lu ZX
    Int J Tuberc Lung Dis; 2013 May; 17(5):615-20. PubMed ID: 23575326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of interview methods to ascertain fluoroquinolone exposure before tuberculosis diagnosis.
    Van Der Heijden YF; Maruri F; Holt E; Mitchel E; Warkentin J; Sterling TR
    Epidemiol Infect; 2015 Apr; 143(5):960-5. PubMed ID: 25420688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increasing outpatient fluoroquinolone exposure before tuberculosis diagnosis and impact on culture-negative disease.
    Gaba PD; Haley C; Griffin MR; Mitchel E; Warkentin J; Holt E; Baggett P; Sterling TR
    Arch Intern Med; 2007 Nov; 167(21):2317-22. PubMed ID: 18039990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluoroquinolone resistance and mutational profile of gyrA in pulmonary MDR tuberculosis patients.
    Kabir S; Tahir Z; Mukhtar N; Sohail M; Saqalein M; Rehman A
    BMC Pulm Med; 2020 May; 20(1):138. PubMed ID: 32393213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current prospects for the fluoroquinolones as first-line tuberculosis therapy.
    Takiff H; Guerrero E
    Antimicrob Agents Chemother; 2011 Dec; 55(12):5421-9. PubMed ID: 21876059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors for mortality among MDR- and XDR-TB patients in a high HIV prevalence setting.
    Gandhi NR; Andrews JR; Brust JC; Montreuil R; Weissman D; Heo M; Moll AP; Friedland GH; Shah NS
    Int J Tuberc Lung Dis; 2012 Jan; 16(1):90-7. PubMed ID: 22236852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcomes and follow-up of patients treated for multidrug-resistant tuberculosis in Orel, Russia, 2002-2005.
    Cavanaugh JS; Kazennyy BY; Nguyen ML; Kiryanova EV; Vitek E; Khorosheva TM; Nemtsova E; Cegielski JP
    Int J Tuberc Lung Dis; 2012 Aug; 16(8):1069-74. PubMed ID: 22691694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chest X-ray vs. Xpert® MTB/RIF assay for the diagnosis of sputum smear-negative tuberculosis in Uganda.
    Wekesa C; Kirenga BJ; Joloba ML; Bwanga F; Katamba A; Kamya MR
    Int J Tuberc Lung Dis; 2014 Feb; 18(2):216-9. PubMed ID: 24429316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Longer delay in accessing treatment among current smokers with new sputum smear-positive tuberculosis in Nepal.
    Bam TS; Enarson DA; Hinderaker SG; Bam DS
    Int J Tuberc Lung Dis; 2012 Jun; 16(6):822-7. PubMed ID: 22507563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding.
    Hanifa Y; Fielding KL; Charalambous S; Variava E; Luke B; Churchyard GJ; Grant AD
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1252-9. PubMed ID: 22794030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence-based Definition for Extensively Drug-Resistant Tuberculosis.
    Roelens M; Battista Migliori G; Rozanova L; Estill J; Campbell JR; Cegielski JP; Tiberi S; Palmero D; Fox GJ; Guglielmetti L; Sotgiu G; Brust JCM; Bang D; Lienhardt C; Lange C; Menzies D; Keiser O; Raviglione M
    Am J Respir Crit Care Med; 2021 Sep; 204(6):713-722. PubMed ID: 34107231
    [No Abstract]   [Full Text] [Related]  

  • 38. Lipoarabinomannan in sputum to detect bacterial load and treatment response in patients with pulmonary tuberculosis: Analytic validation and evaluation in two cohorts.
    Kawasaki M; Echiverri C; Raymond L; Cadena E; Reside E; Gler MT; Oda T; Ito R; Higashiyama R; Katsuragi K; Liu Y
    PLoS Med; 2019 Apr; 16(4):e1002780. PubMed ID: 30978194
    [TBL] [Abstract][Full Text] [Related]  

  • 39. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
    API Consensus Expert Committee
    J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major genotype families and epidemic clones of Mycobacterium tuberculosis in Omsk region, Western Siberia, Russia, marked by a high burden of tuberculosis-HIV coinfection.
    Pasechnik O; Vyazovaya A; Vitriv S; Tatarintseva M; Blokh A; Stasenko V; Mokrousov I
    Tuberculosis (Edinb); 2018 Jan; 108():163-168. PubMed ID: 29523319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.